Telo Genomics Corp.
TDSGF
$0.03
$0.003.57%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 261.80K | 187.70K | 193.40K | 282.90K | 344.30K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 414.10K | 377.70K | 392.60K | 482.10K | 589.30K |
| Operating Income | -414.10K | -377.70K | -392.60K | -482.10K | -589.30K |
| Income Before Tax | -414.10K | -377.70K | -393.30K | -510.80K | -588.90K |
| Income Tax Expenses | -11.10K | -- | -- | -- | -- |
| Earnings from Continuing Operations | -403.00K | -377.70K | -393.30K | -510.80K | -588.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -403.00K | -377.70K | -393.30K | -510.80K | -588.90K |
| EBIT | -414.10K | -377.70K | -392.60K | -482.10K | -589.30K |
| EBITDA | -393.00K | -363.50K | -390.60K | -480.00K | -587.30K |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 100.43M | 100.43M | 100.39M | 99.97M | 100.02M |
| Average Diluted Shares Outstanding | 100.43M | 100.43M | 100.39M | 99.97M | 100.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |